Published online before print February 28, 2005, doi: 10.1161/01.CIR.0000158434.69180.2D
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;111:1370-1376.)
© 2005 American Heart Association, Inc.
Hypertension |
Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression
From the Framingham Heart Study, Framingham, Mass (T.J.W., J.C.E., C.S.F., R.B.D., D.L., R.S.V.); Cardiology Division (T.J.W.), General Medicine Division (J.B.M.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass; Center for Cardiovascular Disease Prevention (N.R.), Department of Endocrinology, Hypertension, and Diabetes (C.S.F.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; Department of Mathematics (R.B.D.), Statistics and Consulting Unit, Boston University, Boston, Mass; the National Heart, Lung, & Blood Institute (C.S.F., D.L.), Bethesda, Md; and Preventive Medicine and Cardiology Sections (R.S.V.), Boston Medical Center, Boston University School of Medicine, Boston, Mass.
Correspondence to Ramachandran S. Vasan, MD, Framingham Heart Study, 73 Mt. Wayte Ave, #2, Framingham, MA 01702-5827. E-mail vasan{at}bu.edu
Received August 14, 2004; revision received November 25, 2004; accepted December 20, 2004.
Background— It has been postulated that glomerular hyperfiltration and endothelial dysfunction are early features of essential hypertension that may antedate blood pressure elevation. Microalbuminuria, a marker of glomerular hyperfiltration and endothelial dysfunction, has been described in individuals with established hypertension, but its role as a biomarker of preclinical stages of this disease has not been investigated prospectively.
Methods and Results— We examined the association between urinary albumin excretion and the risks of hypertension and blood pressure progression in 1499 nonhypertensive individuals (58% women) without diabetes. During a mean follow-up of 2.9 years, 230 participants (15%) developed hypertension and 499 (33%) progressed to a higher blood pressure category (defined by the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure). In multivariable logistic regressions that adjusted for known risk factors, the urine albumin-creatinine ratio (UACR) was a significant predictor of incident hypertension (adjusted OR 1.20, 95% CI 1.01 to 1.44, per 1-SD increment in log UACR). Compared with those in the lowest UACR quartile, participants in the highest quartile (men: >6.66 mg/g; women: >15.24 mg/g) had an 
2-fold risk of developing hypertension (adjusted OR 1.93, P=0.006) and 1.5-fold risk of blood pressure progression (adjusted OR 1.45, P=0.03).
Conclusions— Urinary albumin excretion predicts blood pressure progression in nondiabetic, nonhypertensive individuals incrementally over established risk factors and at levels well below the conventional threshold for microalbuminuria. UACR may be a useful biomarker for identifying individuals most likely to develop hypertension.
Key Words: blood pressure • risk factors • hypertension • epidemiology
This article has been cited by other articles:
 |
|
 |
|
  S. De Cosmo, N. Motterlini, S. Prudente, F. Pellegrini, R. Trevisan, A. Bossi, G. Remuzzi, V. Trischitta, P. Ruggenenti, and on behalf of the BENEDICT Study Group Impact of the PPAR-{gamma}2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT Diabetes, December 1, 2009; 58(12): 2920 - 2929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Forman, N. D.L. Fisher, E. L. Schopick, and G. C. Curhan Higher Levels of Albuminuria within the Normal Range Predict Incident Hypertension J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1983 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Dhaun, J. Goddard, D. E. Kohan, D. M. Pollock, E. L. Schiffrin, and D. J. Webb Role of Endothelin-1 in Clinical Hypertension: 20 Years On Hypertension, September 1, 2008; 52(3): 452 - 459. [Full Text] [PDF]
|
|
|
|
|
|
W. Lieb, M. J. Pencina, T. J. Wang, M. G. Larson, K. J. Lanier, E. J. Benjamin, D. Levy, G. H. Tofler, J. B. Meigs, C. Newton-Cheh, et al. Association of Parental Hypertension With Concentrations of Select Biomarkers in Nonhypertensive Offspring Hypertension, August 1, 2008; 52(2): 381 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mimran and G. du Cailar Dietary sodium: the dark horse amongst cardiovascular and renal risk factors Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2138 - 2141. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Danziger Importance of Low-Grade Albuminuria Mayo Clin. Proc., July 1, 2008; 83(7): 806 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kestenbaum, K. D. Rudser, I. H. de Boer, C. A. Peralta, L. F. Fried, M. G. Shlipak, W. Palmas, C. Stehman-Breen, and D. S. Siscovick Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis Ann Intern Med, April 1, 2008; 148(7): 501 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Hanevold, J. S. Pollock, and G. A. Harshfield Racial Differences in Microalbumin Excretion in Healthy Adolescents Hypertension, February 1, 2008; 51(2): 334 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Salles, R. Fiszman, C. R.L. Cardoso, and E. S. Muxfeldt Relation of Left Ventricular Hypertrophy With Systemic Inflammation and Endothelial Damage in Resistant Hypertension Hypertension, October 1, 2007; 50(4): 723 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ingelsson, M. J. Pencina, G. H. Tofler, E. J. Benjamin, K. J. Lanier, P. F. Jacques, C. S. Fox, J. B. Meigs, D. Levy, M. G. Larson, et al. Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors: The Framingham Offspring Study Circulation, August 28, 2007; 116(9): 984 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ingelsson, J. Sundstrom, L. Lind, U. Riserus, A. Larsson, S. Basu, and J. Arnlov Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men Eur. Heart J., July 2, 2007; 28(14): 1739 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wang, P. Gona, M. G. Larson, D. Levy, E. J. Benjamin, G. H. Tofler, P. F. Jacques, J. B. Meigs, N. Rifai, J. Selhub, et al. Multiple Biomarkers and the Risk of Incident Hypertension Hypertension, March 1, 2007; 49(3): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lieb, B. Mayer, J. Stritzke, A. Doering, H.-W. Hense, H. Loewel, J. Erdmann, and H. Schunkert Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: The MONICA/KORA Augsburg Echocardiographic Substudy Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2780 - 2787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. de Jong and G. C. Curhan Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2120 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Dhaun, J. Goddard, and DavidJ. Webb The Endothelin System and Its Antagonism in Chronic Kidney Disease J. Am. Soc. Nephrol., April 1, 2006; 17(4): 943 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Brantsma, S. J.L. Bakker, D. de Zeeuw, P. E. de Jong, R. T. Gansevoort, and for the PREVEND Study Group Urinary Albumin Excretion as a Predictor of the Development of Hypertension in the General Population J. Am. Soc. Nephrol., February 1, 2006; 17(2): 331 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Palatini, T. J. Wang, J. C. Evans, J. B. Meigs, N. Rifai, C. S. Fox, R. B. D'Agostino, D. Levy, and R. S. Vasan Letter Regarding Article by Wang et al, "Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression" * Response Circulation, August 30, 2005; 112(9): e121 - e121. [Full Text] [PDF]
|
|
|
|
 |
|
 Low-Grade Microalbuminuria Predicts Hypertension Journal Watch (General), May 10, 2005; 2005(510): 1 - 1. [Full Text]
|
|